Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05543707
What this trial is testing

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

Who this might be right for
COVID-19
Pardes Biosciences, Inc. 242
Early research (Phase 1)Study completedNCT00671671
What this trial is testing

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Who this might be right for
Hepatitis, ChronicHepatitis C Virus
Pfizer 20
Not applicableStudy completedNCT01402583
What this trial is testing

Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Prof. Facchinetti Fabio 1,000
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT00621166
What this trial is testing

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Testing effectiveness (Phase 2)Study completedNCT00355524
What this trial is testing

Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

Who this might be right for
HIV-1HIV Infections
Tibotec Pharmaceuticals, Ireland 80
Large-scale testing (Phase 3)Study completedNCT04292730
What this trial is testing

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Who this might be right for
COVID-19
Gilead Sciences 1,113
Not applicableUnknownNCT04344171
What this trial is testing

CovidDB: The Covid-19 Inpatient Database

Who this might be right for
COVID-19
ClarData 5,000
Testing effectiveness (Phase 2)Study completedNCT02367313
What this trial is testing

Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Who this might be right for
Asthma
Biota Pharmaceuticals, Inc. 455
Testing effectiveness (Phase 2)Study completedNCT00019240
What this trial is testing

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Post-approval studies (Phase 4)UnknownNCT04316377
What this trial is testing

Norwegian Coronavirus Disease 2019 Study

Who this might be right for
Corona Virus Infection
University Hospital, Akershus 53
Post-approval studies (Phase 4)Study completedNCT00296153
What this trial is testing

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Who this might be right for
Human Immunodeficiency VirusIschemic Heart Disease
Pronova BioPharma 51
Testing effectiveness (Phase 2)Study completedNCT03258502
What this trial is testing

Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 66
Large-scale testing (Phase 3)Ended earlyNCT04417257
What this trial is testing

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

Who this might be right for
COVID-19 Disease
Laurent Pharmaceuticals Inc. 351
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Testing effectiveness (Phase 2)Study completedNCT04596839
What this trial is testing

Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)

Who this might be right for
Covid19
Dr. Md. Alimur Reza 60
Early research (Phase 1)Study completedNCT02668367
What this trial is testing

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 36
Large-scale testing (Phase 3)Study completedNCT01079806
What this trial is testing

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus, Pediatric
Bristol-Myers Squibb 180
Testing effectiveness (Phase 2)Study completedNCT02226952
What this trial is testing

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 51
Early research (Phase 1)Study completedNCT00000792
What this trial is testing

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation